Genelux (GNLX) Liabilities and Shareholders Equity (2022 - 2026)

Genelux's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $32.4 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $32.4 million; the TTM figure through Mar 2026 stood at $108.6 million (down 9.6% YoY), while the FY2025 annual figure was $19.0 million, down 45.19% from the prior year.
• Liabilities and Shareholders Equity was $32.4 million for Q1 2026 at Genelux, up from $19.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $45.2 million in Q2 2024 to a low of $5.5 million in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $29.2 million across 5 years, with a median of $32.2 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity soared 404.3% in 2023, then tumbled 45.19% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $5.5 million in 2022, then jumped by 404.3% to $27.9 million in 2023, then increased by 24.46% to $34.7 million in 2024, then tumbled by 45.19% to $19.0 million in 2025, then surged by 70.14% to $32.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $32.4 million (Q1 2026), $19.0 million (Q4 2025), and $25.0 million (Q3 2025), per Business Quant data.